Kim Se Ik, Ha Hyeong In, Eoh Kyung Jin, Lim Jiwon, Won Young-Joo, Lim Myong Cheol
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea.
Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Front Oncol. 2022 Apr 7;12:874037. doi: 10.3389/fonc.2022.874037. eCollection 2022.
To compare the incidence and survival rates of primary ovarian clear cell carcinoma (OCCC) and ovarian serous carcinoma (OSC) from a nationwide collected database.
We extracted information of patients with primary OCCC and OSC from the Korea Central Cancer Registry recorded between 1999 and 2018, including age at diagnosis and the Surveillance, Epidemiology, and End Results summary stage. Age-standardized incidence rates (ASRs) and annual percent changes (APCs) were calculated. Baseline characteristics and overall survival (OS) were compared between the OCCC and OSC groups.
Overall, the incidence rate of primary OCCC increased markedly from 1999 (ASR, 0.16/100,000) to 2018 (0.76/100,000) (APC, 7.85%; <0.0001). Patients with OCCC were significantly younger and had early-stage disease more frequently than those with OSC. Patients diagnosed with OCCC before the age of 50 showed better OS than those diagnosed after the age of 50 (=0.0048). The 5-year OS of the OCCC group did not differ by study period [73.5% (1999-2008) vs. 75.4% (2009-2018), =0.3187], whereas the 5-year OS of the OSC group improved from 54.4% to 58% (=0.0003).
Our nationwide registry-based study demonstrated that the incidence of OCCC in Korea increased significantly from 1999 to 2018. Early-stage OCCC had a relatively good prognosis, but advanced-stage OCCC had a worse OS than advanced-stage OSC. Therefore, the development of optimal treatment strategies for OCCC is warranted.
通过一个全国性收集的数据库比较原发性卵巢透明细胞癌(OCCC)和卵巢浆液性癌(OSC)的发病率及生存率。
我们从韩国中央癌症登记处提取了1999年至2018年间记录的原发性OCCC和OSC患者的信息,包括诊断时的年龄以及监测、流行病学和最终结果总结阶段。计算年龄标准化发病率(ASR)和年度百分比变化(APC)。比较OCCC组和OSC组的基线特征及总生存期(OS)。
总体而言,原发性OCCC的发病率从1999年的0.16/10万显著增加至2018年的0.76/10万(APC,7.85%;<0.0001)。与OSC患者相比,OCCC患者明显更年轻,且早期疾病更为常见。50岁之前诊断为OCCC的患者的OS优于50岁之后诊断的患者(P = 0.0048)。OCCC组的5年OS在不同研究期间无差异[73.5%(1999 - 2008年)对75.4%(2009 - 2018年),P = 0.3187],而OSC组的5年OS从54.4%提高至58%(P = 0.0003)。
我们基于全国登记处的研究表明,1999年至2018年韩国OCCC的发病率显著增加。早期OCCC预后相对较好,但晚期OCCC的OS比晚期OSC更差。因此,有必要制定针对OCCC的最佳治疗策略。